in order to evaluate whether the reduced effect of domperidone in diabetics was due to alterations of the dopaminergic control of tsh and prl secretion , the domperidone test was repeated in 6 normal controls and in 6 diabetics of group ii after infusion of dopamine ( 4 micrograms/kg/min for 2 h ) .
C0282151
dopaminergic
C0013030
dopamine